YD Bio Ltd Changes Independent Auditor
Ticker: YDESW · Form: 6-K · Filed: Sep 19, 2025 · CIK: 2011674
| Field | Detail |
|---|---|
| Company | Yd Bio Ltd (YDESW) |
| Form Type | 6-K |
| Filed Date | Sep 19, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, company-news
TL;DR
YD Bio dumped its auditor CBIZ CPAs P.C. on Sept 16.
AI Summary
YD Bio Limited announced on September 16, 2025, that it has changed its independent registered public accounting firm. The company notified CBIZ CPAs P.C. that their services would not be continued.
Why It Matters
A change in auditor can sometimes signal underlying issues or a strategic shift within a company, potentially impacting investor confidence.
Risk Assessment
Risk Level: low — This filing is a routine notification of a change in auditor and does not contain information about financial performance or significant operational changes.
Key Players & Entities
- YD Bio Limited (company) — Registrant
- CBIZ CPAs P.C. (company) — Previous independent registered public accounting firm
- September 16, 2025 (date) — Date of notification
FAQ
What is the exact date YD Bio Limited notified its previous auditor of the non-continuation of services?
YD Bio Limited notified CBIZ CPAs P.C. on September 16, 2025.
Who is the former independent registered public accounting firm for YD Bio Limited?
The former independent registered public accounting firm was CBIZ CPAs P.C.
What is the filing type and date for this report?
This is a Form 6-K filed for the month of September 2025, with the filing date as of September 19, 2025.
What is the principal executive office address for YD Bio Limited?
The principal executive office is located at 12F., No. 3, Xingnan St., Nangang Dist., Taipei City 115001, Taiwan.
Does YD Bio Limited file annual reports under Form 20-F or Form 40-F?
YD Bio Limited files annual reports under cover of Form 20-F.
Filing Stats: 806 words · 3 min read · ~3 pages · Grade level 16.8 · Accepted 2025-09-19 16:30:01
Filing Documents
- ea0257812-6k_ydbio.htm (6-K) — 17KB
- ea025781201ex16-1_ydbio.htm (EX-16.1) — 4KB
- ex16-1_001.jpg (GRAPHIC) — 6KB
- ex16-1_002.jpg (GRAPHIC) — 5KB
- ex16-1_003.jpg (GRAPHIC) — 4KB
- 0001213900-25-089562.txt ( ) — 44KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. YD Bio Limited By: /s/ Edmund Hen Name: Edmund Hen Title: Chief Financial Officer Date: September 19, 2025 3